Funding
Turn ideas into impact
Show Me
Due: November 18, 2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
US $300,000
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-034
Due: November 20, 2027
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Type
Cooperative Agreement
Source
Federal
Opp Number
W911NF-23-S-0001
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-055
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-056
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
US $275,000
Type
Grant
Source
Federal
Due: December 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products – Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-017
Due: December 23, 2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-020
Due: December 23, 2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-019
Due: December 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products – Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-018
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?